SIBN
SI-BONE, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$24.93
+4.89%Year over year
Reported trailing growth
- Revenue
- +14.0%
- EBITDA
- +71.3%
- EBIT
- +34.1%
- EPS
- +39.3%
- Free cash flow
- +60.5%
- Operating cash flow
- +596.6%
Forward estimates
Based on analyst estimates
- Revenue
- +17.1%
- EBITDA
- -54.8%
- EPS
- -17.9%
Three-year CAGR
- Revenue
- +23.6%
- EBITDA
- +52.8%
- EBIT
- +36.6%
- Net income
- +38.8%
- EPS
- +41.3%
- Free cash flow
- +60.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026